David Easson

David Easson is an accomplished professional with extensive experience in the biotechnology and pharmaceutical industries, currently serving as Chief Manufacturing Officer at Solarea Bio since 2020. Easson has held significant positions in various organizations, including Board Member at Massachusetts Biomedical Initiatives since 2019, VP of Bioprocess and Head of Manufacturing Tech Transfer at Indigo from 2016 to 2020, and Head of Manufacturing at AOBiome from 2014 to 2016. Easson's earlier roles involved leadership in bioprocess projects at IMPACT Technology Development, directing operations at Worcester Polytechnic Institute's Life Sciences and Bioengineering Center, and holding senior roles at Baxter Healthcare and Epic Therapeutics. Easson's academic credentials include a PhD in Bio Chemical Engineering from the Massachusetts Institute of Technology and a BS in Chemical Engineering from the University of South Carolina.